These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 14514140)
1. Implanted pacemaker failure caused by the antirheumatic drug hydroxychloroquine. Huang PH; Tuan TC; Lin YJ; Ding YA; Kong CW Lupus; 2003; 12(9):725-7. PubMed ID: 14514140 [No Abstract] [Full Text] [Related]
2. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis. Unübol M; Ayhan M; Guney E J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846 [No Abstract] [Full Text] [Related]
3. Hydroxychloroquine-induced hyperpigmentation. Cho EB; Kim BC; Park EJ; Kwon IH; Cho HJ; Kim KH; Kim KJ J Dermatol; 2012 Oct; 39(10):859-60. PubMed ID: 22671572 [No Abstract] [Full Text] [Related]
9. Evidence for risk of cardiomyopathy with hydroxychloroquine. Sumpter MD; Tatro LS; Stoecker WV; Rader RK Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986 [No Abstract] [Full Text] [Related]
10. Cutaneous hyperpigmentation during therapy with hydroxychloroquine. Amichai B; Gat A; Grunwald MH J Clin Rheumatol; 2007 Apr; 13(2):113. PubMed ID: 17414546 [No Abstract] [Full Text] [Related]
11. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Seçkin U; Ozoran K; Ikinciogullari A; Borman P; Bostan EE Rheumatol Int; 2000; 19(5):203-4. PubMed ID: 10984140 [TBL] [Abstract][Full Text] [Related]
12. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine. Easterbrook M J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662 [No Abstract] [Full Text] [Related]
13. Hydroxychloroquine retinopathy: is screening necessary? Blyth C; Lane C BMJ; 1998 Mar; 316(7133):716-7. PubMed ID: 9529393 [No Abstract] [Full Text] [Related]